Guizhou Bailing Group Pharmaceutical Co., Ltd.
SHZ: 002424.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wei Jiang
- Employees
- 6,582
- Headquarters
- Anshun, China
- IPO year
- 2010
- Market cap
- CN¥6.9B
- Website
- https://www.gzbl.com
Loading 002424…
Loading profile data…Frequently asked questions about 002424
What does Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) do?
Guizhou Bailing Group Pharmaceutical Co., Ltd. researches, develops, produces, and sells Chinese medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, pills, powders, tinctures, sprays, and ointments for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases....
Where does 002424.SZ trade?
Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002424.SZ in?
Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Guizhou Bailing Group Pharmaceutical Co., Ltd.?
Wei Jiang is the chief executive officer of Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ).
Where is Guizhou Bailing Group Pharmaceutical Co., Ltd. headquartered?
Guizhou Bailing Group Pharmaceutical Co., Ltd. is headquartered in China.
Does 002424.SZ pay a dividend?
Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 002424.SZ go public?
Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ) completed its initial public offering in 2010.